# reload+after+2024-01-21 22:34:40.590515
address1§10 Sylvan Way
city§Parsippany
state§NJ
zip§07054
country§United States
phone§973 822 7000
website§https://www.zoetis.com
industry§Drug Manufacturers—Specialty & Generic
sector§Healthcare
longBusinessSummary§Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. The company also offers parasiticides; vaccines; anti-infectives; other pharmaceutical products; dermatology; and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products and laboratory; and other non-pharmaceutical products. It markets its products to veterinarians, livestock producers, and pet owners. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
fullTimeEmployees§13800
companyOfficers§[{'maxAge': 1, 'name': 'Ms. Kristin C. Peck', 'age': 52, 'title': 'CEO & Director', 'yearBorn': 1971, 'fiscalYear': 2022, 'totalPay': 2803733, 'exercisedValue': 3050826, 'unexercisedValue': 13434981}, {'maxAge': 1, 'name': 'Mr. Wetteny N. Joseph', 'age': 51, 'title': 'Executive VP & CFO', 'yearBorn': 1972, 'fiscalYear': 2022, 'totalPay': 1255348, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Wafaa  Mamilli', 'age': 56, 'title': 'EVP, Chief Digital & Tech. Officer, Group President for China, Brazil and Preci. Animal Health', 'yearBorn': 1967, 'fiscalYear': 2022, 'totalPay': 1078161, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Heidi C. Chen', 'age': 56, 'title': 'Executive VP, General Counsel, Corporate Secretary & Business Lead of Human Health Diagnostics', 'yearBorn': 1967, 'fiscalYear': 2022, 'totalPay': 1035947, 'exercisedValue': 0, 'unexercisedValue': 880936}, {'maxAge': 1, 'name': 'Ms. Roxanne  Lagano', 'age': 58, 'title': 'Executive VP and Chief Human Resources Officer & Global Operations', 'yearBorn': 1965, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Steven  Frank', 'title': 'Vice President of Investor Relations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. William  Price', 'title': 'VP & Chief Communications Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Robert J. Polzer Ph.D.', 'age': 54, 'title': 'Executive VP and President of Research & Development', 'yearBorn': 1969, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Jeannette Ferran Astorga', 'age': 48, 'title': 'Executive VP of Corporate Affairs & Communications and Chief Sustainability Officer', 'yearBorn': 1975, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Nick  Ashton', 'age': 50, 'title': 'Executive VP and President of Global Manufacturing & Supply', 'yearBorn': 1973, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§5
boardRisk§1
compensationRisk§2
shareHolderRightsRisk§7
overallRisk§3
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
dividendRate§1.73
dividendYield§0.0089
exDividendDate§1705536000
payoutRatio§0.2953
fiveYearAvgDividendYield§0.62
beta§0.848
priceToSalesTrailing12Months§10.6867
currency§USD
dateShortInterest§1702598400
forwardEps§6.04
pegRatio§3.43
exchange§NYQ
quoteType§EQUITY
shortName§Zoetis Inc.
longName§Zoetis Inc.
firstTradeDateEpochUtc§1359729000
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§e8724ae7-5c8b-3a4a-927d-2a11631a1cf4
gmtOffSetMilliseconds§-18000000
targetHighPrice§255.0
targetLowPrice§190.0
targetMeanPrice§219.0
targetMedianPrice§220.0
recommendationMean§1.8
recommendationKey§buy
numberOfAnalystOpinions§12
quickRatio§1.873
earningsGrowth§0.142
grossMargins§0.70398
ebitdaMargins§0.41487998
trailingPegRatio§3.2506
